biotech stocks

AcnEase® Blog Named Best Skin Care Blog of 2017 for Third Consecutive Year

CEO William “Bill” Hartman, Premier Biomedical, Interviewed on Stu Taylor Radio Show

Daily Pick for 1/12/17

Columnist Dr. Gifford Jones Shares Why He Invested into Eastgate Biotech

Eastgate Biotech CEO, Anna Gluskin, Talks about Developing First Insulin Delivery Method by Oral Administration

Guy LaTorre, Breathtec Biomedical, Explains New Breath Technology to Detect Life-Threatening Illnesses

CEO Rob Hutchison discusses Target Therapeutic Areas of Focus for biOasis Technologies

Premier Biomedical Pain Management Solutions Announces Shipment of Initial Samples of Opioid-Free, 50-State Legal, CBD-Based Pain-Relieving Topical Patch

Innovus Pharmaceuticals Well Capitalized with the Closing of $1.5M in Financing from Institutional Investors

James McGorry, CEO with Biostage, Inc., Explains their Cellframe™ Technology Platform with Uptick Network

Anna Gluskin, CEO with Eastgate Biotech Corp., Discusses their New Delivery Method for Insulin

SECFilings.com Examines Innovus Pharmaceuticals' (INNV) Position in Multi-Billion Dollar Female Sexual Dysfunction Market

Alpine Creek and BioCorRx Announce Major Investment into BioCorRx

Wally Klemp, with Moleculin Biotech, Inc. (MBRX), discusses on Uptick Network their new treatment for Second-Line Leukemia Patients

Innovus Pharmaceuticals Eliminates Over $1.8M in Liabilities